Srinivas is the Founder and Managing General Partner at Samsara BioCapital. His previous positions include General Partner of Sofinnova Ventures, Managing Director of New Leaf Venture Partners, and Co-Founder and Managing Director at Panorama Capital, LLC, a private equity firm. Prior to co-founding Panorama Capital, Srinivas was a Partner with J.P. Morgan Partners. He also worked in Business and Corporate Development at Genentech (now a wholly owned member of The Roche Group), a biotechnology company.
Prior to joining Genentech, Srinivas was a graduate student at Stanford University, where he received his M.D. and a Ph.D. in Immunology. He received his undergraduate degrees in Biochemistry and Computer Science from Rice University. Srinivas serves as a Director of Chinook Therapeutics, Intercept Pharmaceuticals, Syros Pharmaceuticals, and Jiya Acquisition Corp. Previously, he served as a Director on the boards of Seattle Genetics, Principia Biopharma, Aravive, Inc., Barrier Therapeutics, Eyetech Pharmaceuticals, ZS Pharma, Synageva Biopharma Corp., and Amarin Corporation.